Lucid Diagnostics Inc.
NASDAQ:LUCD
0.945 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|
Operating Activities: | ||||||
Net Income
| -52.666 | -56.171 | -28.078 | -8.28 | -4.421 | -1.126 |
Depreciation & Amortization
| 2.499 | 1.936 | 0.004 | 0 | 0 | 0 |
Deferred Income Tax
| -5,766.937 | 0 | -10.472 | 0 | 0 | 0 |
Stock Based Compensation
| 6.822 | 14.991 | 9.599 | 0.065 | 0.174 | 0.08 |
Change In Working Capital
| 5.675 | 8.906 | 0.807 | 2.585 | 1.885 | 0.72 |
Accounts Receivables
| -0.028 | 0.183 | -0.2 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 0.089 | -0.445 | -0.665 | 1.146 | 0.302 | 0.497 |
Other Working Capital
| 5.614 | 9.168 | 1.672 | 1.439 | 1.583 | 0.223 |
Other Non Cash Items
| 5,771.79 | 0.653 | 10.472 | -1.081 | -0.128 | -0.205 |
Operating Cash Flow
| -32.817 | -29.685 | -17.668 | -5.629 | -2.361 | -0.114 |
Investing Activities: | ||||||
Investments In Property Plant And Equipment
| -0.221 | -0.908 | -0.862 | 0 | 0 | 0 |
Acquisitions Net
| 0 | -3.2 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| -221 | -3.2 | -862 | 0 | 0 | 0 |
Investing Cash Flow
| -0.221 | -4.108 | -0.862 | 0 | 0 | 0 |
Financing Activities: | ||||||
Debt Repayment
| -10 | 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 29.46 | 2.611 | 70 | 5.583 | 2.5 | 0.132 |
Common Stock Repurchased
| 551 | 109 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 10,284 | 2.611 | 2.075 | 5.579 | 2.5 | 0.197 |
Financing Cash Flow
| 29.46 | 2.611 | 72.075 | 5.583 | 2.5 | 0.132 |
Other Information: | ||||||
Effect Of Forex Changes On Cash
| -3,574.422 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -3.578 | -31.182 | 53.545 | -0.045 | 0.139 | 0.018 |
Cash At End Of Period
| 18.896 | 22.474 | 53.656 | 0.111 | 0.156 | 0.018 |